CocrystalPharmaInc.jpg
Cocrystal Pharma Reports 2019 Financial Results and Outlines Expected Value-Driving Milestones for 2020
March 30, 2020 06:05 ET | Cocrystal Pharma, Inc.
Advancing preclinical COVID-19 Coronavirus program leveraging patent rights recently acquired from Kansas State University Research Foundation (“KSURF”) Continuing collaboration with Merck to discover...
CocrystalPharmaInc.jpg
Cocrystal Pharma Announces Plans to Advance Coronavirus Program
March 06, 2020 16:01 ET | Cocrystal Pharma, Inc.
Company has immediately initiated Coronavirus programLeveraging patent rights recently acquired from Kansas State University Research Foundation (“KSURF”) Strong financial position bolsters Company’s...
CocrystalPharmaInc.jpg
Cocrystal Pharma, Inc. Announces License Agreement with Kansas State University Research Foundation for Norovirus and Coronavirus Antiviral Compounds
February 24, 2020 08:00 ET | Cocrystal Pharma, Inc.
BOTHELL, WA, Feb. 24, 2020 (GLOBE NEWSWIRE) -- - Company acquires rights to preclinical leads for Norovirus and Coronavirus therapeutics - - Proprietary platform technology will be used to...
A Microbiologist's Approach to Identifying & Avoiding Food Poisoning
February 02, 2016 15:34 ET | ARUP Laboratories
SALT LAKE CITY, Feb. 2, 2016 (GLOBE NEWSWIRE) -- Chipotle is in the midst of a restaurant's nightmare, as it contends with the consequences of three major foodborne outbreaks this past year involving...